切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2017, Vol. 03 ›› Issue (02) : 114 -118. doi: 10.3877/cma.j.issn.2095-9141.2017.02.013

所属专题: 文献

综述

Ⅱ型神经纤维瘤病治疗策略
陈立华1,(), 徐如祥1   
  1. 1. 100700 北京,陆军总医院附属八一脑科医院
  • 收稿日期:2017-01-09 出版日期:2017-04-15
  • 通信作者: 陈立华

Treatment strategies of neurofibromatosis type Ⅱ

Lihua Chen1,(), Ruxiang Xu1   

  1. 1. The Affiliated Bayi Brain Hospital, The Military General Hospital, Beijing 100700, China
  • Received:2017-01-09 Published:2017-04-15
  • Corresponding author: Lihua Chen
  • About author:
    Corresponding author: Chen Lihua, Email:
引用本文:

陈立华, 徐如祥. Ⅱ型神经纤维瘤病治疗策略[J/OL]. 中华神经创伤外科电子杂志, 2017, 03(02): 114-118.

Lihua Chen, Ruxiang Xu. Treatment strategies of neurofibromatosis type Ⅱ[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2017, 03(02): 114-118.

神经纤维瘤病是源于神经嵴细胞分化异常而导致的多系统损害的常染色体显性遗传性疾病,常累及神经、肌肉、骨骼、内脏及皮肤。神经纤维瘤病是一种先天性发育不良性疾病,根据其临床特点和责任基因的不同可分为I型(NF1)和Ⅱ型(NF2)两种类型。与Ⅰ型神经纤维瘤病相比,Ⅱ型神经纤维瘤病的发病率更低。约为3/10万患者发生前庭神经许旺细胞瘤和其他肿瘤,包括脑膜瘤、室管膜瘤和星形细胞瘤等以及外周神经许旺细胞瘤。许多患者还可出现晶状体囊混浊。

Neurofibromatosis is an autosomal dominant disorder caused by abnormal differentiation of neural crest cells, which often involves the nerve, muscle, bone, internal organs and skin. Neurofibromatosis is a congenital development benign disease, according to its clinical characteristics and responsibilities gene of different type can be divided into type I (NF1) and Ⅱ (NF2) two types. Compared with type I, neurofibromatosis type Ⅱ has a lower incidence of neurofibromatosis. About 3/10 of all patients with vestibular nerve schwann cell tumor and other tumours, including meningiomas, ependymoma and astrocytoma and peripheral nerve schwann cell tumor. Many patients also can appear capsule opacity.

[1]
Szudek J, Briggs R, Leung R. Surgery for neurofibromatosis 2[J]. Curr Opin Otolaryngol Head Neck Surg, 2012, 20(5): 347-352.
[2]
赵赋,王博,杨智君,等. 2型神经纤维瘤病前庭神经鞘瘤的显微外科治疗[J].中华神经外科杂志, 2014, 30(11): 1153-1156.
[3]
Plotkin SR, Merker VL, Muzikansky A, et al. Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients[J]. Otol Neurotol, 2014, 35(1): e50-56.
[4]
Shepard TH, Tucci DL, Grant GA, et al. Management of hearing in pediatric NF2[J]. Otol Neurotol, 2012, 33(6): 1066-1070.
[5]
Stachowicz-Stencel T, Synakiewicz A, Bien E, et al. Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 managementstrategy[J]. Childs Nerv Syst, 2011, 27(1): 175-178
[6]
Kontorinis G, Nichani J, Freeman SR, et al. Progress of hearing loss in neurofibromatosis type 2: implications for future management[J]. Eur Arch Otorhinolaryngol, 2015, 272(11): 3143-3150.
[7]
Nowak A, Dziedzic T, Czernicki T, et al. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients[J]. Neurol Neurochir Pol, 2015, 49(6): 367-372.
[8]
Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2[J]. Neurosurgery, 1997, 40(4):696-705.
[9]
van de Langenberg R, Hanssens PE, van Overbeeke JJ, et al. Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by Gamma Knife surgery: radiological and clinical aspects[J]. J Neurosurg, 2011, 115(5): 875-884.
[10]
Rowe J, Radatz M, Kemeny A. Radiosurgery for type II neurofibromatosis[J]. Prog Neurol Surg, 2008, 21: 176-182.
[11]
Rowe JG, Radatz MW, Walton L, et al. Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis[J]. J Neurol Neurosurg Psychiatry, 2003, 74(9): 1288-1293.
[12]
Sharma MS, Singh R, Kale SS, et al. Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas inneurofibromatosis type 2[J]. J Neurooncol, 2010, 98(2): 265-270.
[13]
Subach BR, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2[J]. J Neurosurg, 2013, 119 Suppl: 815-822.
[14]
Mathieu D, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates[J]. Neurosurgery, 2007, 60(3): 460-468.
[15]
Kondziolka D, Subach BR, Lunsford LD, et al. Outcomes after gamma knife radiosurgery in solitary acoustic tumors and neurofibromatosis type 2[J]. Neurosurg Focus, 1998, 5(3): E4.
[16]
Wowra B, Muacevic A, Jess-Hempen A, et al. Outpatient gamma knife surgery for vestibular schwannoma: definition of the therapeutic profile based on a 10-year experience[J]. J Neurosurg, 2013, 119 Suppl: 114-118.
[17]
Maniakas A, Saliba I. Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years′ follow-up[J]. Otol Neurotol, 2012, 33(9): 1611-1620.
[18]
孙健,杨学军,李罡,等. Ⅱ型神经纤维瘤病随访50年一例报告[J].中国现代神经疾病杂志, 2007, 7(4): 327-331.
[19]
Jacob A, Robinson LL Jr, Bortman JS, et a1. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center[J]. Laryngoscope, 2007, 117(12): 2087-2092.
[20]
Samii M, Gerganov V, Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results[J]. Prog Neurol Surg, 2008, 21: 169-175.
[21]
Moffat DA, Lloyd SK, Macfarlane R, et al. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2[J]. Br J Neurosurg, 2013, 27(4): 446-453.
[22]
Odat HA, Piccirillo E, Sequino G, et al. Management strategy of vestibular schwannoma in neurofibromatosis type 2[J]. Otol Neurotol, 2011, 32(7): 1163-1170.
[23]
Tysome JR, Macfarlane R, Durie-Gair J, et al. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2[J]. Otol Neurotol, 2012, 33(3): 466-472.
[24]
Martuza RL, E1dridge R. Neufofibromatosis 2(bilateral acoutic neurofibromatosis)[J]. N Engl J Med, 1988, 318(11): 684-688.
[25]
陈炳恒,王象昌,王宜崇.一次性切除两侧听神经瘤并保留面神经的成功经验[J].中华神经外科杂志, 1985, 1(4): 209.
[26]
Slattery WH, Hoa M, Bonne N, et a1. Middle fossa decompression for hearing preservation:a review of institutional results and indications[J]. Otol Neurotol, 2011, 32(6): 1017-1024.
[27]
Montgomery BK, Alimchandani M, Mehta GU, et al. Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2[J]. Clin Neuropathol, 2016, 35(2): 78-83.
[28]
Di Maio S, Malebranche AD, Westerberg B, et al. Hearing preservation after microsurgical resection of large vestibular schwannomas[J]. Neurosurgery, 2011, 68(3): 632-640.
[29]
Strauss C, Bischoff B, Romstöck J, et al. Hearing preservation in medial vestibular schwannomas[J]. J Neurosurg, 2008, 109(1): 70-76.
[30]
Chen LH, Chen L, Liu L, et al. Vestibular schwannoma microsurgery with special reference to facial nerve preservation[J]. Clin Neurol Neurosurg, 2009, 111(1): 47-53.
[31]
Brackmann DE, Fayad JN, Slattery WH 3rd, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2[J]. Neurosurgery, 2001, 49(2): 274-280.
[32]
Nowak A, Dziedzic T, Czernicki T, et al. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2[J]. Neurol Neurochir Pol, 2015, 49(5): 295-301.
[33]
Slattery WH 3 rd, Fisher LM, Hitselberger W, et a1. Hearing preservation surgery-for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients[J]. J Neurosurg, 2007, 106 (4 Suppl): 255-260.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[13] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[15] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?